Cost-per-kit test contract for chemistry immunoassays testing reagent kits
Ended Purchase Order Awarded Last action
- Contract number
- W81K0025PA185
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,323,229
Award facts
- Opportunity
-
- Solicitation- Chemistry Immunoassays testing reagents- WBAMC Solicitation · W81K0025QA091 · Posted Jul 16, 2025
- Contract value 54% obligated
- $2,455,184.37 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Bliss, TX 79918, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $79,621 | |
| Funding Only Action | $1,131,955 | |
| Exercise an Option | $0 | |
| Original award | $111,653 |
About this award
The Defense Health Agency awarded a purchase order to Roche Diagnostics Corporation for cost-per-kit chemistry immunoassay testing reagent kits on September 1, 2025, with a ceiling value of $2,455,184.37 and an ultimate completion date of September 30, 2027. Work is performed at Fort Bliss, Texas. The order covers leasing two chemistry analyzers and two immunoassay analyzers, modular laboratory track line equipment including centrifuges and probe handling systems, and reagent kits supporting over 95 chemistry and immunoassay tests. The underlying solicitation (W81K00-25-Q-A091), posted July 16, 2025, required technical evaluation under Lowest Price Technically Acceptable criteria, including Risk Management Framework obtainment, reagent delivery capability, and information security compliance. The contract structure includes a one-month base period through September 30, 2025, followed by two 12-month option periods at firm fixed prices.
Quick answers
Who was awarded contract W81K0025PA185?
W81K0025PA185 was awarded to Roche Diagnostics Corporation by Medical Command (Department of the Army) on September 1, 2025.
How much is contract W81K0025PA185 worth?
The government has obligated $1,323,229 on W81K0025PA185. Its current value, with exercised options, is $2,455,184.
Which agency awarded contract W81K0025PA185?
Medical Command (Department of the Army) awarded W81K0025PA185, with funding from Defense Health Agency (Department of Defense).
Was contract W81K0025PA185 competed?
The extent of competition for W81K0025PA185 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award